Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Optimax Holdings BhdXKLS:0222 +0.96%68 5-Year Yield-on-Cost % is 2.69 as of Jul. 29, 2026, which is 4% above its 10-year median of 2.58. GuruFocus rates XKLS:0222 with a GF Score™ of 68/100 and a GF Value™ of RM0.76 (Significantly Undervalued). The stock has 2 warning signs investors should review. Among 277 Healthcare Providers & Services companies, Optimax Holdings Bhd ranks worse than 53.07% on this metric.
Optimax Holdings Bhd's yield on cost for the quarter that ended in Mar. 2026 was 2.69.
The historical rank and industry rank for Optimax Holdings Bhd's 5-Year Yield-on-Cost % or its related term are showing as below:
XKLS:0222'
s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 1.55 Med: 2.58 Max: 3.84
Current: 2.69
During the past 10 years, Optimax Holdings Bhd's highest Yield on Cost was 3.84. The lowest was 1.55. And the median was 2.58.
XKLS:0222's 5-Year Yield-on-Cost % is ranked worse than 53.07% of 277
companies
in the Healthcare Providers & Services industry
Industry Median: 2.93
vs XKLS:0222: 2.69
Optimax Holdings Bhd (XKLS:0222) 5-Year Yield-on-Cost % Explanation
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
Optimax Holdings Bhd 5-Year Yield-on-Cost % Related Terms
XKLS:0222 vs HCA, THC, DVA: 5-Year Yield-on-Cost % Comparison
For the Medical Care Facilities subindustry, Optimax Holdings Bhd's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Optimax Holdings Bhd 5-Year Yield-on-Cost % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Optimax Holdings Bhd's 5-Year Yield-on-Cost % distribution charts can be found below:
* The bar in red indicates where Optimax Holdings Bhd's 5-Year Yield-on-Cost % falls into.
Optimax Holdings Bhd 5-Year Yield-on-Cost % Calculation
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
Optimax Holdings Bhd (XKLS:0222) has a 5-Year Yield-on-Cost % of 2.69 as of Jul. 29, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Optimax Holdings Bhd and its competitors. This is near median its historical median of 2.58. Over the past decade, Optimax Holdings Bhd's 5-Year Yield-on-Cost % has ranged from 1.55 to 3.84. According to the industry distribution chart, Optimax Holdings Bhd ranks #147 out of 277 companies in the Healthcare Providers & Services industry, placing it in the top 53.1%.
Is Optimax Holdings Bhd's 5-Year Yield-on-Cost % too high?
Optimax Holdings Bhd's current 5-Year Yield-on-Cost % of 2.69 is near median its 10-year median of 2.58. Over the past 10 years, this metric has ranged from a low of 1.55 to a high of 3.84. The Healthcare Providers & Services industry median 5-Year Yield-on-Cost % is 2.93. Optimax Holdings Bhd's value of 2.69 is 8.2% below this industry median. Based on the distribution chart, Optimax Holdings Bhd ranks #147 out of 277 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Optimax Holdings Bhd has a GF Score™ of 68/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Optimax Holdings Bhd's 5-Year Yield-on-Cost % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Optimax Holdings Bhd ranks #147 out of 277 companies for 5-Year Yield-on-Cost %. This places Optimax Holdings Bhd in the lower half of its industry. The industry median 5-Year Yield-on-Cost % is 2.93. Optimax Holdings Bhd's value of 2.69 is 8.2% below this benchmark. Historically, Optimax Holdings Bhd's own 5-Year Yield-on-Cost % has ranged from 1.55 to 3.84 over the past decade. While the company's 10-year median is 2.58 vs. the industry median of 2.93, Optimax Holdings Bhd has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Healthcare Providers & Services company?
The median 5-Year Yield-on-Cost % among Healthcare Providers & Services companies is 2.93, based on 277 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Optimax Holdings Bhd's current 5-Year Yield-on-Cost % of 2.69 is 8.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Optimax Holdings Bhd and its competitors. For the Healthcare Providers & Services industry, the median 5-Year Yield-on-Cost % is 2.93 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Optimax Holdings Bhd's current 5-Year Yield-on-Cost % is 2.69, which is near median its own 10-year median of 2.58. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Optimax Holdings Bhd stock overvalued right now?
Based on GuruFocus' analysis, Optimax Holdings Bhd (XKLS:0222) is currently considered Significantly Undervalued. The stock's GF Value™ is RM0.76, compared to a current price of RM0.53 — trading 30.9% below its estimated fair value. The current 5-Year Yield-on-Cost % is 2.69, which is near median its 10-year median of 2.58 and 8.2% below the Healthcare Providers & Services industry median of 2.93. Optimax Holdings Bhd's overall GF Score™ is 68/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For Optimax Holdings Bhd (XKLS:0222), the current 5-Year Yield-on-Cost % is 2.69 as of Jul. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Optimax Holdings Bhd (XKLS:0222) Overvalued in 2026?
Based on GuruFocus' analysis, Optimax Holdings Bhd stock appears to be undervalued.
The current stock price of RM0.53 is trading 30.9% below its estimated GF Value™ of RM0.76.
GuruFocus considers Optimax Holdings Bhd to be Significantly Undervalued.
Key valuation signals for XKLS:0222:
5-Year Yield-on-Cost %: 2.69 (near median its 10-year median of 2.58)
GF Value™: RM0.76 vs. price of RM0.53 (30.9% below fair value)
Industry Position: 8.2% below the Healthcare Providers & Services median (#147 of 277)
No single metric tells the full story. See the XKLS:0222 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Optimax Holdings Bhd is a provider of eye specialist services. The company offers a range of services with in-house medical ophthalmology at specialist centres such as specialist clinics, ambulatory care centres, satellite clinics, and specialist hospitals. The company's ambulatory care centres and specialist hospital are equipped with eye operation theatres, and procedure rooms, general and day care wards, and relevant equipment for surgical procedures. It derives revenue from refractive surgery, treatment of eye diseases and disorders, consultation and dispensary services, oculoplastic surgery, plastic Surgery and aesthetic Services and related services. The company operates in geographical segments such as: North Malaysia, Central Malaysia, South Malaysia, East Malaysia and Cambodia.
68GF Score
Get the complete analysis for XKLS:0222
5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XKLS:0222 has been successfully added to your 
